Skip to main content

26.11.2019 | Original Research

Three-dimensional (3D) printed tablets using ethyl cellulose and hydroxypropyl cellulose to achieve zero order sustained release profile

verfasst von: Shiva Homaee Borujeni, Seyedeh Zahra Mirdamadian, Jaleh Varshosaz, Azade Taheri

Erschienen in: Cellulose

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

The main objective of this study was to investigate the potential of coupling hot-melt extrusion (HME) and 3D printing in order to design drug containing matrix tablets for the purpose of achieving zero order release. The effect of the blend ratio of ethyl cellulose (EC) and hydroxypropyl cellulose (HPC), carbamazepine (CBZ) as a model drug and triethyl citrate (TEC) on the mechanical and printability properties of extruded filaments was investigated. Filament formulation containing CBZ, EC and HPC (3, 64.7 and 32.3% w/w, respectively) and 20% w/w of TEC (by weight on the dry powder) showed optimum mechanical and printability properties and subsequently was printed into tablets (370 mg, 13 mm diameter, 3.5 mm thickness, cylinder-shaped) at 187 °C. The printed tablets showed good uniformity in drug content and appropriate mechanical properties. The optimum filament showed first order drug release pattern, while the 3D printed tablets showed zero-order drug release and slower drug release rate than the optimum filament. Overall, we have demonstrated that zero order release tablets can be prepared from a 2:1 ratio of EC to HPC, by combination of HME and 3D printing technologies with the capability of reducing dose frequency and adverse effects of drugs.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Literatur
Zurück zum Zitat Arafat B, Qinna N, Cieszynska M, Forbes RT, Alhnan MA (2018a) Tailored on demand anti-coagulant dosing: an in vitro and in vivo evaluation of 3D printed purpose-designed oral dosage forms. Eur J Pharm Biopharm 128:282–289PubMed Arafat B, Qinna N, Cieszynska M, Forbes RT, Alhnan MA (2018a) Tailored on demand anti-coagulant dosing: an in vitro and in vivo evaluation of 3D printed purpose-designed oral dosage forms. Eur J Pharm Biopharm 128:282–289PubMed
Zurück zum Zitat Arafat B, Wojsz M, Isreb A, Forbes RT, Isreb M, Ahmed W, Arafat T, Alhnan MA (2018b) Tablet fragmentation without a disintegrant: a novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets. Eur J Pharm Sci 118:191–199PubMed Arafat B, Wojsz M, Isreb A, Forbes RT, Isreb M, Ahmed W, Arafat T, Alhnan MA (2018b) Tablet fragmentation without a disintegrant: a novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets. Eur J Pharm Sci 118:191–199PubMed
Zurück zum Zitat Bijarimi M, Ahmad S, Rasid R, Khushairi M, Zakir M (2016) Poly (lactic acid)/poly (ethylene glycol) blends: mechanical, thermal and morphological properties. In: AIP Conference Proceedings, AIP Publishing, p 020002 Bijarimi M, Ahmad S, Rasid R, Khushairi M, Zakir M (2016) Poly (lactic acid)/poly (ethylene glycol) blends: mechanical, thermal and morphological properties. In: AIP Conference Proceedings, AIP Publishing, p 020002
Zurück zum Zitat Boetker J, Water JJ, Aho J, Arnfast L, Bohr A, Rantanen J (2016) Modifying release characteristics from 3D printed drug-eluting products. Eur J Pharm Sci 90:47–52PubMed Boetker J, Water JJ, Aho J, Arnfast L, Bohr A, Rantanen J (2016) Modifying release characteristics from 3D printed drug-eluting products. Eur J Pharm Sci 90:47–52PubMed
Zurück zum Zitat Bruschi ML (2015) Strategies to modify the drug release from pharmaceutical systems. Woodhead Publishing, Cambridge Bruschi ML (2015) Strategies to modify the drug release from pharmaceutical systems. Woodhead Publishing, Cambridge
Zurück zum Zitat Chen L, Yang G, Chu X, Gao C, Wang Y, Gong W, Li Z, Yang Y, Yang M, Gao C (2019) Polymer distribution and mechanism conversion in multiple media of phase-separated controlled-release film-coating. Pharmaceutics 11(2):80PubMedCentral Chen L, Yang G, Chu X, Gao C, Wang Y, Gong W, Li Z, Yang Y, Yang M, Gao C (2019) Polymer distribution and mechanism conversion in multiple media of phase-separated controlled-release film-coating. Pharmaceutics 11(2):80PubMedCentral
Zurück zum Zitat Claeys B, Vervaeck A, Hillewaere XK, Possemiers S, Hansen L, De Beer T, Remon JP, Vervaet C (2015) Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding. Eur J Pharm Biopharm 90:44–52PubMed Claeys B, Vervaeck A, Hillewaere XK, Possemiers S, Hansen L, De Beer T, Remon JP, Vervaet C (2015) Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding. Eur J Pharm Biopharm 90:44–52PubMed
Zurück zum Zitat De Brabander C, Van den Mooter G, Vervaet C, Remon JP (2002) Characterization of ibuprofen as a nontraditional plasticizer of ethyl cellulose. J Pharm Sci 91(7):1678–1685 De Brabander C, Van den Mooter G, Vervaet C, Remon JP (2002) Characterization of ibuprofen as a nontraditional plasticizer of ethyl cellulose. J Pharm Sci 91(7):1678–1685
Zurück zum Zitat Djuris J, Nikolakakis I, Ibric S, Djuric Z, Kachrimanis K (2013) Preparation of carbamazepine–Soluplus® solid dispersions by hot-melt extrusion, and prediction of drug–polymer miscibility by thermodynamic model fitting. Eur J Pharm Biopharm 84(1):228–237PubMed Djuris J, Nikolakakis I, Ibric S, Djuric Z, Kachrimanis K (2013) Preparation of carbamazepine–Soluplus® solid dispersions by hot-melt extrusion, and prediction of drug–polymer miscibility by thermodynamic model fitting. Eur J Pharm Biopharm 84(1):228–237PubMed
Zurück zum Zitat Fan W, Zhu W, Zhang X, Xu Y, Di L (2019) Application of the combination of ball-milling and hot-melt extrusion in the development of an amorphous solid dispersion of a poorly water-soluble drug with high melting point. RSC Adv 9(39):22263–22273 Fan W, Zhu W, Zhang X, Xu Y, Di L (2019) Application of the combination of ball-milling and hot-melt extrusion in the development of an amorphous solid dispersion of a poorly water-soluble drug with high melting point. RSC Adv 9(39):22263–22273
Zurück zum Zitat Farto-Vaamonde X, Auriemma G, Aquino RP, Concheiro A, Alvarez-Lorenzo C (2019) Post-manufacture loading of filaments and 3D printed PLA scaffolds with prednisolone and dexamethasone for tissue regeneration applications. Eur J Pharm Biopharm 141:100–110PubMed Farto-Vaamonde X, Auriemma G, Aquino RP, Concheiro A, Alvarez-Lorenzo C (2019) Post-manufacture loading of filaments and 3D printed PLA scaffolds with prednisolone and dexamethasone for tissue regeneration applications. Eur J Pharm Biopharm 141:100–110PubMed
Zurück zum Zitat Fuenmayor E, Forde M, Healy A, Devine D, Lyons J, McConville C, Major I (2018) Material considerations for fused-filament fabrication of solid dosage forms. Pharmaceutics 10(2):44PubMedCentral Fuenmayor E, Forde M, Healy A, Devine D, Lyons J, McConville C, Major I (2018) Material considerations for fused-filament fabrication of solid dosage forms. Pharmaceutics 10(2):44PubMedCentral
Zurück zum Zitat Gareb B, Eissens AC, Kosterink JG, Frijlink HW (2016) Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease. Eur J Pharm Biopharm 103:32–42PubMed Gareb B, Eissens AC, Kosterink JG, Frijlink HW (2016) Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease. Eur J Pharm Biopharm 103:32–42PubMed
Zurück zum Zitat Goyanes A, Buanz AB, Basit AW, Gaisford S (2014) Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm 476(1–2):88–92PubMed Goyanes A, Buanz AB, Basit AW, Gaisford S (2014) Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm 476(1–2):88–92PubMed
Zurück zum Zitat Goyanes A, Wang J, Buanz A, Martínez-Pacheco R, Telford R, Gaisford S, Basit AW (2015) 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol Pharm 12(11):4077–4084PubMed Goyanes A, Wang J, Buanz A, Martínez-Pacheco R, Telford R, Gaisford S, Basit AW (2015) 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol Pharm 12(11):4077–4084PubMed
Zurück zum Zitat Goyanes A, Kobayashi M, Martínez-Pacheco R, Gaisford S, Basit AW (2016) Fused-filament 3D printing of drug products: microstructure analysis and drug release characteristics of PVA-based caplets. Int J Pharm 514(1):290–295PubMed Goyanes A, Kobayashi M, Martínez-Pacheco R, Gaisford S, Basit AW (2016) Fused-filament 3D printing of drug products: microstructure analysis and drug release characteristics of PVA-based caplets. Int J Pharm 514(1):290–295PubMed
Zurück zum Zitat Goyanes A, Allahham N, Trenfield SJ, Stoyanov E, Gasiford S, Basit AW (2019) Direct powder extrusion 3D printing: fabrication of drug products using a novel, single-step process. Int J Pharm 567:118471PubMed Goyanes A, Allahham N, Trenfield SJ, Stoyanov E, Gasiford S, Basit AW (2019) Direct powder extrusion 3D printing: fabrication of drug products using a novel, single-step process. Int J Pharm 567:118471PubMed
Zurück zum Zitat Guo F, Wu F, Mu Y, Hu Y, Zhao X, Meng W, Giesy JP, Lin Y (2016) Characterization of organic matter of plants from lakes by thermal analysis in a N 2 atmosphere. Sci Rep 6:22877PubMedPubMedCentral Guo F, Wu F, Mu Y, Hu Y, Zhao X, Meng W, Giesy JP, Lin Y (2016) Characterization of organic matter of plants from lakes by thermal analysis in a N 2 atmosphere. Sci Rep 6:22877PubMedPubMedCentral
Zurück zum Zitat Huang S, O’Donnell KP, Keen JM, Rickard MA, McGinity JW, Williams RO (2016) A new extrudable form of hypromellose: AFFINISOL™ HPMC HME. AAPS Pharmscitech 17(1):106–119PubMed Huang S, O’Donnell KP, Keen JM, Rickard MA, McGinity JW, Williams RO (2016) A new extrudable form of hypromellose: AFFINISOL™ HPMC HME. AAPS Pharmscitech 17(1):106–119PubMed
Zurück zum Zitat Islam MT, Scoutaris N, Maniruzzaman M, Moradiya HG, Halsey SA, Bradley MS, Chowdhry BZ, Snowden MJ, Douroumis D (2015) Implementation of transmission NIR as a PAT tool for monitoring drug transformation during HME processing. Eur J Pharm Biopharm 96:106–116PubMed Islam MT, Scoutaris N, Maniruzzaman M, Moradiya HG, Halsey SA, Bradley MS, Chowdhry BZ, Snowden MJ, Douroumis D (2015) Implementation of transmission NIR as a PAT tool for monitoring drug transformation during HME processing. Eur J Pharm Biopharm 96:106–116PubMed
Zurück zum Zitat Jamróz W, Kurek M, Łyszczarz E, Szafraniec J, Knapik-Kowalczuk J, Syrek K, Paluch M, Jachowicz R (2017) 3D printed orodispersible films with Aripiprazole. Int J Pharm 533(2):413–420PubMed Jamróz W, Kurek M, Łyszczarz E, Szafraniec J, Knapik-Kowalczuk J, Syrek K, Paluch M, Jachowicz R (2017) 3D printed orodispersible films with Aripiprazole. Int J Pharm 533(2):413–420PubMed
Zurück zum Zitat Jamróz W, Szafraniec J, Kurek M, Jachowicz R (2018) 3D printing in pharmaceutical and medical applications–recent achievements and challenges. Pharm Res 35(9):176PubMedPubMedCentral Jamróz W, Szafraniec J, Kurek M, Jachowicz R (2018) 3D printing in pharmaceutical and medical applications–recent achievements and challenges. Pharm Res 35(9):176PubMedPubMedCentral
Zurück zum Zitat Kadry H, Wadnap S, Xu C, Ahsan F (2019) Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets. Eur J Pharm Sci 135:60–67PubMed Kadry H, Wadnap S, Xu C, Ahsan F (2019) Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets. Eur J Pharm Sci 135:60–67PubMed
Zurück zum Zitat Kamel R, Abbas H (2018) PLGA-based monolithic filaments prepared by hot-melt extrusion: in-vitro comparative study. Annales Pharmaceutiques Francaises 76:97–106PubMed Kamel R, Abbas H (2018) PLGA-based monolithic filaments prepared by hot-melt extrusion: in-vitro comparative study. Annales Pharmaceutiques Francaises 76:97–106PubMed
Zurück zum Zitat Khaled SA, Alexander MR, Irvine DJ, Wildman RD, Wallace MJ, Sharpe S, Yoo J, Roberts CJ (2018) Extrusion 3D printing of paracetamol tablets from a single formulation with tunable release profiles through control of tablet geometry. AAPS Pharmscitech 19(8):3403–3413PubMedPubMedCentral Khaled SA, Alexander MR, Irvine DJ, Wildman RD, Wallace MJ, Sharpe S, Yoo J, Roberts CJ (2018) Extrusion 3D printing of paracetamol tablets from a single formulation with tunable release profiles through control of tablet geometry. AAPS Pharmscitech 19(8):3403–3413PubMedPubMedCentral
Zurück zum Zitat Kou W, Cai C, Xu S, Wang H, Liu J, Yang D, Zhang T (2011) In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC. Int J Pharm 409(1–2):75–80PubMed Kou W, Cai C, Xu S, Wang H, Liu J, Yang D, Zhang T (2011) In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC. Int J Pharm 409(1–2):75–80PubMed
Zurück zum Zitat Kovacevic I, Parojcic J, Homšek I, Tubic-Grozdanis M, Langguth P (2008) Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation. Mol Pharm 6(1):40–47 Kovacevic I, Parojcic J, Homšek I, Tubic-Grozdanis M, Langguth P (2008) Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation. Mol Pharm 6(1):40–47
Zurück zum Zitat Koester LS, Xavier CR, Mayorga P, Bassani VL (2003) Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. Eur J Pharm Biopharm 55(1):85–91PubMed Koester LS, Xavier CR, Mayorga P, Bassani VL (2003) Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. Eur J Pharm Biopharm 55(1):85–91PubMed
Zurück zum Zitat Ledwon P, Andrade JR, Lapkowski M, Pawlicka A (2015) Hydroxypropyl cellulose-based gel electrolyte for electrochromic devices. Electrochim Acta 159:227–233 Ledwon P, Andrade JR, Lapkowski M, Pawlicka A (2015) Hydroxypropyl cellulose-based gel electrolyte for electrochromic devices. Electrochim Acta 159:227–233
Zurück zum Zitat Li QJ, Wen HY, Jia DY, Guan XY, Pan H, Yang Y, Yu SH, Zhu ZH, Xiang RW, Pan WS (2017) Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing. Int J Pharm 525:5–11PubMed Li QJ, Wen HY, Jia DY, Guan XY, Pan H, Yang Y, Yu SH, Zhu ZH, Xiang RW, Pan WS (2017) Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing. Int J Pharm 525:5–11PubMed
Zurück zum Zitat Lim SH, Chia SMY, Kang L, Yap KYL (2016) Three-dimensional printing of carbamazepine sustained-release scaffold. J Pharm Sci 105(7):2155–2163PubMed Lim SH, Chia SMY, Kang L, Yap KYL (2016) Three-dimensional printing of carbamazepine sustained-release scaffold. J Pharm Sci 105(7):2155–2163PubMed
Zurück zum Zitat Löscher W (1998) New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342(1):1–13PubMed Löscher W (1998) New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342(1):1–13PubMed
Zurück zum Zitat Lu M (2019) Novel excipients and materials used in FDM 3D printing of pharmaceutical dosage forms. 3D and 4D printing in biomedical applications: process engineering and additive manufacturing. Wiley, New York, pp 211–237 Lu M (2019) Novel excipients and materials used in FDM 3D printing of pharmaceutical dosage forms. 3D and 4D printing in biomedical applications: process engineering and additive manufacturing. Wiley, New York, pp 211–237
Zurück zum Zitat Medarević DP, Kachrimanis K, Mitrić M, Djuriš J, Djurić Z, Ibrić S (2016) Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions. Pharm Dev Technol 21(3):268–276PubMed Medarević DP, Kachrimanis K, Mitrić M, Djuriš J, Djurić Z, Ibrić S (2016) Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions. Pharm Dev Technol 21(3):268–276PubMed
Zurück zum Zitat Mujtaba A, Kohli K (2016) In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil. Int J Biol Macromol 89:434–441PubMed Mujtaba A, Kohli K (2016) In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil. Int J Biol Macromol 89:434–441PubMed
Zurück zum Zitat Norman J, Madurawe RD, Moore CM, Khan MA, Khairuzzaman A (2017) A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev 108:39–50PubMed Norman J, Madurawe RD, Moore CM, Khan MA, Khairuzzaman A (2017) A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev 108:39–50PubMed
Zurück zum Zitat Öblom H, Zhang J, Pimparade M, Speer I, Preis M, Repka M, Sandler N (2019) 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release. AAPS Pharmscitech 20(2):52PubMedPubMedCentral Öblom H, Zhang J, Pimparade M, Speer I, Preis M, Repka M, Sandler N (2019) 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release. AAPS Pharmscitech 20(2):52PubMedPubMedCentral
Zurück zum Zitat Palekar S, Nukala PK, Mishra SM, Kipping T, Patel K (2019) Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen. Int J Pharm 556:106–116PubMed Palekar S, Nukala PK, Mishra SM, Kipping T, Patel K (2019) Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen. Int J Pharm 556:106–116PubMed
Zurück zum Zitat Parfitt K (1999) Martindale: the complete drug reference. Pharmaceutical Press, London Parfitt K (1999) Martindale: the complete drug reference. Pharmaceutical Press, London
Zurück zum Zitat Patil H, Tiwari RV, Repka MA (2016) Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS Pharmscitech 17(1):20–42PubMed Patil H, Tiwari RV, Repka MA (2016) Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS Pharmscitech 17(1):20–42PubMed
Zurück zum Zitat Powell G, Saunders M, Rigby A, Marson AG (2010) Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy. Cochrane Database Syst Rev 1:CD007124 Powell G, Saunders M, Rigby A, Marson AG (2010) Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy. Cochrane Database Syst Rev 1:CD007124
Zurück zum Zitat Sadia M, Isreb A, Abbadi I, Isreb M, Aziz D, Selo A, Timmins P, Alhnan MA (2018) From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets. Eur J Pharm Sci 123:484–494PubMed Sadia M, Isreb A, Abbadi I, Isreb M, Aziz D, Selo A, Timmins P, Alhnan MA (2018) From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets. Eur J Pharm Sci 123:484–494PubMed
Zurück zum Zitat Shin TH, Ho MJ, Kim SR, Im SH, Kim CH, Lee S, Kang MJ, Choi YW (2018) Formulation and in vivo pharmacokinetic evaluation of ethyl cellulose-coated sustained release multiple-unit system of tacrolimus. Int J Biol Macromol 109:544–550PubMed Shin TH, Ho MJ, Kim SR, Im SH, Kim CH, Lee S, Kang MJ, Choi YW (2018) Formulation and in vivo pharmacokinetic evaluation of ethyl cellulose-coated sustained release multiple-unit system of tacrolimus. Int J Biol Macromol 109:544–550PubMed
Zurück zum Zitat Skowyra J, Pietrzak K, Alhnan MA (2015) Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci 68:11–17PubMed Skowyra J, Pietrzak K, Alhnan MA (2015) Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci 68:11–17PubMed
Zurück zum Zitat Smith DM, Kapoor Y, Klinzing GR, Procopio AT (2018) Pharmaceutical 3D printing: Design and qualification of a single step print and fill capsule. Int J Pharm 544(1):21–30PubMed Smith DM, Kapoor Y, Klinzing GR, Procopio AT (2018) Pharmaceutical 3D printing: Design and qualification of a single step print and fill capsule. Int J Pharm 544(1):21–30PubMed
Zurück zum Zitat Tagami T, Fukushige K, Ogawa E, Hayashi N, Ozeki T (2017) 3D printing factors important for the fabrication of polyvinylalcohol filament-based tablets. Biol Pharm Bull 40(3):357–364PubMed Tagami T, Fukushige K, Ogawa E, Hayashi N, Ozeki T (2017) 3D printing factors important for the fabrication of polyvinylalcohol filament-based tablets. Biol Pharm Bull 40(3):357–364PubMed
Zurück zum Zitat Tang B, Liu Z, Tian Z, Zhang J, Chen X, Fang G, Song H (2019) Development and evaluation of synchronized and sustained release Tripergium Wilfordii tablets based hot-melt extrusion and direct powder compression. J Drug Deliv Sci Technol 53:101208 Tang B, Liu Z, Tian Z, Zhang J, Chen X, Fang G, Song H (2019) Development and evaluation of synchronized and sustained release Tripergium Wilfordii tablets based hot-melt extrusion and direct powder compression. J Drug Deliv Sci Technol 53:101208
Zurück zum Zitat Tiwari RV, Patil H, Repka MA (2016) Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century. Expert Opin Drug Deliv 13(3):451–464PubMed Tiwari RV, Patil H, Repka MA (2016) Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century. Expert Opin Drug Deliv 13(3):451–464PubMed
Zurück zum Zitat Wiranidchapong C, Ruangpayungsak N, Suwattanasuk P, Shuwisitkul D, Tanvichien S (2015) Plasticizing effect of ibuprofen induced an alteration of drug released from Kollidon SR matrices produced by direct compression. Drug Dev Ind Pharm 41(6):1037–1046PubMed Wiranidchapong C, Ruangpayungsak N, Suwattanasuk P, Shuwisitkul D, Tanvichien S (2015) Plasticizing effect of ibuprofen induced an alteration of drug released from Kollidon SR matrices produced by direct compression. Drug Dev Ind Pharm 41(6):1037–1046PubMed
Zurück zum Zitat Yang Y, Wang H, Li H, Ou Z, Yang G (2018) 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release. Eur J Pharm Sci 115:11–18 Yang Y, Wang H, Li H, Ou Z, Yang G (2018) 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release. Eur J Pharm Sci 115:11–18
Zurück zum Zitat Zhang J, Feng X, Patil H, Tiwari RV, Repka MA (2017) Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int J Pharm 519(1–2):186–197PubMed Zhang J, Feng X, Patil H, Tiwari RV, Repka MA (2017) Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int J Pharm 519(1–2):186–197PubMed
Zurück zum Zitat Zhang J, Xu P, Vo AQ, Bandari S, Yang F, Durig T, Repka MA (2019) Development and evaluation of pharmaceutical 3D printability for hot melt extruded cellulose-based filaments. J Drug Deliv Sci Technol 52:292–302 Zhang J, Xu P, Vo AQ, Bandari S, Yang F, Durig T, Repka MA (2019) Development and evaluation of pharmaceutical 3D printability for hot melt extruded cellulose-based filaments. J Drug Deliv Sci Technol 52:292–302
Metadaten
Titel
Three-dimensional (3D) printed tablets using ethyl cellulose and hydroxypropyl cellulose to achieve zero order sustained release profile
verfasst von
Shiva Homaee Borujeni
Seyedeh Zahra Mirdamadian
Jaleh Varshosaz
Azade Taheri
Publikationsdatum
26.11.2019
Verlag
Springer Netherlands
Erschienen in
Cellulose
Print ISSN: 0969-0239
Elektronische ISSN: 1572-882X
DOI
https://doi.org/10.1007/s10570-019-02881-4